Ocuvite Eye Health App
For Ocuvite, Bausch & Lomb’s long-established eye health supplement brand, we designed a comprehensive mobile app that lets users track their eye health as part of their daily routine. Combining medical credibility with a clean, accessible experience, the app brings together a broad feature set ranging from screen-time management to supplement reminders.
- For Bausch & Lomb’s Ocuvite brand, we designed a comprehensive mobile health app, available on iOS and Android, that turns eye health into a daily routine.
- Built for a wide audience from people in their 30s to those over 60, it delivers an accessible experience with large fonts, high contrast and simplified navigation.
- Since launch, more than 46,000 dry eye risk assessments have been completed, and 30-day user retention reached 63% (versus a category average of 25%).
Challenge
The target audience spanned a wide spectrum, from users in their 30s to those over 60. Finding a design language that felt both modern and accessible across these two extremes was critical. Striking the delicate balance between the simplicity of medical content and scientific credibility posed a significant challenge.
Solution
Following extensive discovery research conducted with eye health specialists and representatives of the target audience, we defined the app’s core feature set. A screen-time tracker, a dry eye risk assessment and a personalized supplement program became the three main pillars of the app. Large fonts, high-contrast options and simplified navigation ensured accessibility across the broad age range.
Results & Impact
Since launch, more than 46,000 users have completed the in-app dry eye risk assessment, providing Bausch+Lomb with valuable first-party health data. Users who enabled the daily supplement reminder showed an 87% engagement rate, while 30-day retention reached 63% — well above the 25% average for the health app category. The app was cited as a UX benchmark for the health field in Turkey’s leading pharmaceutical industry publications.
